“Bimekizumab 4-year Efficacy in High-impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s432. doi:10.25251/skin.8.supp.432.